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A SIRTain role in pancreatic β cell function
Genes formerly thought to be involved solely in the regulation of life span have increasingly become implicated in the
regulation of metabolic processes. Moynihan et al. (2005 [this issue of Cell Metabolism]) now demonstrate that increasing
levels of Sirt1 in the pancreatic β cells of mice result in a more efficient glucose handling due to enhanced glucose-
stimulated insulin secretion.The idea that life span and calorie in-
take/handling might be interrelated is w
not new. Classic literature and recent c
data show that restricted calorie intake g
extends life span of a number of organ- S
isms including yeast, worms, flies, and S
even mammals (Guarente and Picard,
(2005). A study in this issue of Cell Me-
ltabolism now shows how nutrient sens-
oing in the endocrine pancreas may be
taffected by one of the key genes in-
volved in modulating life span. d80Sir2 (silent information regulator 2) d
as first identified in yeast for its role in S
hromatin remodeling associated with N
ene silencing and prolonged life span. m
IRT1, the mammalian ortholog of yeast o
ir2, is one of seven mammalian sirtuins s
Sirt1–7). Sirt1 is a protein deacetylase, t
ocated in the cell nucleus. It requires v
xidized NAD as a cofactor and is nega- u
ively regulated by either NADH or the m
eacetylation product nicotinamide. A becrease in the NAD/NADH ratio inhibits
irt1 activity, and this dependency on
AD may link Sirt1 activity to cellular
etabolic changes. In higher eukary-
tes, the role of Sirt1 has been mainly
tudied in the context of calorie restric-
ion, a condition that results in Sirt1 acti-
ation. In differentiated fat cells, upreg-
lation of Sirt1 triggers lipolysis and
obilization of free fatty acids into the
lood (Picard et al., 2004). In liver cells,CELL METABOLISM : AUGUST 2005
P R E V I E Wactivation of Sirt1 leads to the inactiva- t
tion of glycolysis, and the activation of a
gluconeogenesis, which results in an in- h
creased hepatic glucose output (Rod- p
gers et al., 2005). c
The phenotype of a mouse that over- p
expresses Sirt1 in the pancreatic β cell, f
i.e., BESTO mice, is now described by r
Moynihan and coworkers. Most interest- l
ingly, BESTO mice exhibit an improved t
glucose tolerance due to enhanced glu- g
cose-stimulated insulin secretion (GSIS). t
The pancreatic β cell is a very efficient 6
fuel sensor that immediately converts c
the blood glucose concentration into c
gsignals that allow both the release andb
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iFigure 1. Sirt1 as a potential master-switch in β cell function
aSchematic illustration of the potential role of Sirt1 in β cell function. As a deacetylase of histones, transcription
gfactors and coregulators Sirt1 can modulate the expression profile of the β cell and thereby regulate key
events in glucose-stimulated insulin secretion (GSIS), such as glycolysis, oxidative phosphorylation, and exo- i
cytosis. GSIS starts with the uptake of glucose by glucose transporters and proceeds with the metabolism of c
glucose, an increase in NAD(P)H, in glycolysis and Krebs cycle, resulting in the formation of ATP. The resting
hmembrane potential of the pancreatic β cell is set by the ATP-sensitive potassium (KATP) channel. Elevation
rin the ATP/ADP ratio leads to closure of KATP channels, which in turn results in depolarization of the plasma
membrane. The subsequent opening of voltage-gated L type Ca2+ channels leads to an increase in the g
cytoplasmic free Ca2+ concentration, which promotes insulin exocytosis. Depicted is also the normally occur- s
ring negative feedback of insulin on Sirt1 expression (Cohen et al., 2004), which is disrupted in the BESTO i
mice where Sirt1 expression is now driven by the insulin promoter, the latter being positively regulated by
linsulin (Leibiger et al., 1998).
c
e
TCELL METABOLISM : AUGUST 2005βhe production of insulin in adequate
cmounts in order to maintain glucose
comeostasis. In doing so, the β cell de-
dends on an efficient metabolism of glu-
pose by glycolysis and oxidative phos-
fhorylation. The complex processes that
dinally result in insulin exocytosis, often
oeferred to as the glucose-stimulus-insu-
Sin-secretion coupling, start with the up-
eake of glucose by high-Km/low-affinity
clucose transporters and proceed with
she conversion of glucose into glucose-
e-phosphate by the β cell isoform of glu-
Sokinase. Metabolism of glucose by gly-
aolysis and the Krebs cycle results in the
eneration of ATP. The resting mem- orane potential of the pancreatic β cell
s set by the ATP-sensitive potassium
KATP) channel. Elevation in the ATP/ADP
atio leads to closure of KATP channels,
hich in turn results in depolarization of
he plasma membrane. The subsequent
pening of voltage-gated L type Ca2+
hannels leads to an increase in the cy-
oplasmic free Ca2+ concentration, which
romotes insulin secretion.
Sirt1 has previously been shown to af-
ect glucose metabolism in liver cells by
ctivating the transcriptional coactivator
GC-1α, with subsequent expression of
luconeogenic genes and repression of
lycolytic genes (Rodgers et al., 2005).
n agreement with these results, overex-
ression of PGC-1α in pancreatic β cells
eads to the activation of the gluco-
eogenic gene glucose-6-phosphatase
nd repression of genes involved in β
ell glucose uptake and glycolysis with
marked inhibition of GSIS (Yoon et al.,
003). Noteworthy is that normal pan-
reatic islets express both PGC-1α
Yoon et al., 2003) and Sirt1 (Moynihan
t al., 2005) at low levels. Hence, in light
f these data and the central role of glu-
ose metabolism in GSIS, the results of
he study by Moynihan et al. might at
irst sight seem unexpected. If one pos-
ts that overexpression of Sirt1 in β cells
ctivates PGC-1α, thereby repressing
lycolysis, one would expect a decrease
n ATP production and, hence, a de-
reased GSIS. On the contrary, Moyni-
an and coworkers find an increase,
ather than a decrease, in ATP levels in
lucose-stimulated BESTO β cells. As-
uming no changes or even a reduction
n the glycolytic flux, the higher ATP
evels could be explained by a more effi-
ient oxidative phosphorylation, which is
xactly what Moynihan et al. report.
hey find that overexpression of Sirt1 in
cells leads to the repression of the un-
oupling protein UCP2. UCPs are mito-
hondrial inner-membrane proteins that
uring oxidative phosphorylation uncou-
le the process of oxygen consumption
rom ATP generation, which also re-
uces the amount of produced reactive
xygen species (ROS). The finding that
irt1 overexpression downregulates UCP2
xpression is of general importance be-
ause the relation between calorie re-
triction, and thus Sir2 activity, and UCP
xpression is unclear. Given the role of
ir2 in calorie restriction and longevity
nd the currently assumed central role
f ROS in aging (see Guarente and Pi-81
P R E V I E Wcard, 2005), the situation becomes rather v
complex. Downregulation of UCPs would 2
reduce uncoupling and allow a more ef- s
ficient ATP production under circum- s
stances of limited access to nutrients.
On the other hand, upregulation of UCP b
would suppress production of ROS and i
thus be favorable because of reduced d
oxidative damage and “aging” of cells. f
Since Sirt1 represses UCP2 expression, a
increasing Sirt1 activity/dosage may also 1
have implications as a potential thera- u
peutic strategy in diabetes. However, t
downregulation of UCP2 could lead to a
an increase in ROS production and hence H
increase the risk of β cell damage, espe- i
cially under diabetic conditions. Using p
Sirt1 activity/dosage as a target might
q
therefore be contraindicated and, in any
tcase, needs much more experimental
wand clinical work for verification. In this
Scontext, it remains to be proven whether
the observed phenotype of the BESTO
I
mice reflects the “amplification” of func-
tion of the endogenous Sirt1 in the pan-
a
T
creatic β cell, as assumed by the au-
thors, or whether overexpression of Sirt1
D
should rather be interpreted as a “tool”
to manipulate β cell function. This is es-
K
pecially interesting in the light of insulin
S
feedback on β cell function (Leibiger et
S
al., 1998; Kulkarni et al., 1999; Uhles et
al., 2003). Insulin may activate genes in-82Solved in glycolysis (Leibiger et al.,
001), and endogenous Sirt1 expression
C
eems to be negatively regulated by in- N
oulin (Cohen et al., 2004).
SDownregulation of UCP2 expression
Gy Sirt1 in β cells is only the tip of the
4ceberg. Aside from its role as a histone
Keacetylase, and its involvement there-
Pore in chromatin remodeling, and the
(
bove discussed modulation of PGC-
Lα, Sirt1 has also been shown to reg-
g
late the activity of transcription fac-
Lors and transcription coregulators such
K
s p53, Ku70, FoxO1, NF-κB, PPARγ, B
NF4α, and p300, all of them implicated
M
n regulation of gene expression in the B
ancreatic β cell (Figure 1). Thus the P
2uestion as to whether further investiga-
ions of sirtuins in β cell function are P
Aorthwhile has to be answered: yes,
MIRTainly! N
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